Vasopressor and Inotropic Therapy Flashcards
Vasopressors
Drugs that cause vasoconstriction
Inotropes
Change the strength of contraction
Chronotropes
Change the rate of contraction
Indications for therapy
Decrease in SBP of >30 mmHg from baseline with clinical signs/symptomatology
Decrease in MAP >60 from baseline
Poor organ perfusion secondary to changes in BP or CO (brain, heart, kidney, etc)
Decreased myocardial contraction
Location of alpha-1/alpha 2 adrenergic receptors
Vascular wall
Heart
Effect of alpha-1/alpha 2 adrenergic receptors
Vascular wall-vasoconstriction
Heart- Increased duration of contraction without increased chronotropy
Location of beta adrenergic receptors
Beta-1: heart
Beta-2: blood vessels, lungs
Effects of beta adrenergic receptors
Heart: increased inotropy and chronotropy
Blood vessels and lungs: vasodilation
Location of dopamine receptors
Renal
Splanchnic
Coronary
Cerebral
Effects of dopamine receptors
Vasodilation
Generic name of Neosynephrine
Phenylephrine
Generic name of Levophed
Norepinephrine
Generic name of Adrenalin
Epinephrine
Generic name of Inotropin
Dopamine
Receptors phenylephrine affects
Alpha-1 (very strong effect)
Predominant clinical effects of phenylephrine
Increased SVR
Increased CO
Receptors norepinephrine affects
Alpha-1 (very
strong effect)
Beta-1 (moderate effect)
Predominant clinical effects of norepinephrine
Increased SVR
Increased CO